Protein kinase Cβ isoform inhibitors: A new treatment for diabetic cardiovascular diseases

Circulation

Volumn 110, Issue 1, 2004, Pages 7-9

  He, Zhiheng ^a   King, George L ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CGP 53352; PROTEIN KINASE C BETA; PROTEIN KINASE INHIBITOR; RUBOXISTAURIN; UNCLASSIFIED DRUG; ENZYME INHIBITOR; PROTEIN KINASE C;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DRUG EFFICACY; DYSLIPIDEMIA; EDITORIAL; ENDOTHELIUM CELL; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR; BIOLOGICAL MODEL; DRUG ANTAGONISM; ENZYMOLOGY; HUMAN; METABOLISM; NOTE; VASCULAR ENDOTHELIUM;

CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; MODELS, BIOLOGICAL; PROTEIN KINASE C;

EID: 3042735579     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000133428.02295.6C     Document Type: Editorial

References (20)

1. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287:2570-2581.
2. Krolewski AS, Warram JH, Valsania P, et al. Evolving natural history of coronary artery disease in diabetes mellitus. Am J Med. 1991;90:56S-61S.
3. Yamasaki Y, Kawamori R, Matsushima H, et al. Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging. Diabetes. 1994;43:634-639.
4. Giannattasio C, Failla M, Grappiolo A, et al. Progression of large artery structural and functional alterations in Type I diabetes. Diabetologia. 2001;44:203-208.
5. Bonora E, Kiechl S, Oberhollenzer F, et al. Impaired glucose tolerance, type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study. Diabetologia. 2000;43:156-164.
6. Nathan DM, Lachin J, Cleary P, et al. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med. 2003;348:2294-2303.
7. Kuboki K, Jiang ZY, Takahara N, et al. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation. 2000;101:676-681.
8. Jiang ZY, Lin YW, Clemont A, et al. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest. 1999;104:447-457.
9. Cosentino F, Eto M, De Paolis P, et al. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation. 2003;107:1017-1023.
10. Beckman JA, Goldfine AB, Gordon MB, et al. Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res. 2002;90:107-111.
11. Hall JL, Matter CM, Wang X, et al. Hyperglycemia inhibits vascular smooth muscle cell apoptosis through a protein kinase C-dependent pathway. Circ Res. 2000;87:574-580.
12. Newton AC. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem J. 2003;370:361-371.
13. Inoguchi T, Battan R, Handler E, et al. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci U S A. 1992;89:11059-11063.
14. Wakasaki H, Koya D, Schoen FJ, et al. Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci U S A. 1997;94:9320-9325.
15. Way KJ, Isshiki K, Suzuma K, et al. Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes. Diabetes. 2002;51:2709-2718.
16. 2 prevents acute effects of high glucose on vascular cell adhesion molecule-1 expression in human endothelial cells Circulation. 2004;110:91-96.
17. Leitges M, Schmedt C, Guinamard R, et al. Immunodeficiency in protein kinase cbeta-deficient mice. Science. 1996;273:788-791.
18. Way KJ, Chou E, King GL. Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol Sci. 2000;21:181-187.
19. Schechtman D, Mochly-Rosen D. Isozyme-specific inhibitors and activators of protein kinase C. Methods Enzymol. 2002;345:470-489.
20. Chou E, Suzuma I, Way KJ, et al. Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states: a possible explanation for impaired collateral formation in cardiac tissue. Circulation. 2002;105:373-379.